{"address1": "10 King Street East", "address2": "Suite 600", "city": "Toronto", "state": "ON", "zip": "M5C 1C3", "country": "Canada", "phone": "877 422 5242", "website": "https://www.medexus.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Medexus Pharmaceuticals Inc. operates as a pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; and Gleolan, an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery. The company's products portfolio also includes Cuvposa, a glycopyrrolate oral solution; Naproxen, a Pediapharm naproxen suspension; Otixal, a ciprofloxacin and flucinolone acetonide; Trispan, a triamcinolone hexacetonide injectable suspension; and Trecondyv, a bifunctional alkylating agent for use as part of a conditioning treatment for patients undergoing allogeneic hematopoietic stem cell transplantation. In addition, it offers over the counter products comprising Nyda, a topical revolutionary treatment indicated for the eradication of head lice; Relaxa, an osmotic laxative to treat occasional constipation in adults; Oralvisc to reduce joint pain and enhance joint function in osteoarthritis of the knee; and Calcia Calcium and vitamin D products. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Toronto, Canada.", "fullTimeEmployees": 82, "companyOfficers": [{"maxAge": 1, "name": "Mr. Kenneth  d'Entremont", "title": "CEO & Director", "fiscalYear": 2024, "totalPay": 1496382, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard  Labelle", "title": "Chief Operating Officer", "fiscalYear": 2024, "totalPay": 497388, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian C. Wildgoose Brown", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2024, "totalPay": 611219, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brendon  Buschman", "title": "Chief Financial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tina  Byers CFA", "title": "Executive of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bill  Poncy", "title": "Senior Vice President of Commercial Operations - United States", "fiscalYear": 2024, "totalPay": 632808, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Peters", "title": "Vice President of Sales & Marketing - United States", "fiscalYear": 2024, "totalPay": 396695, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.49, "open": 2.46, "dayLow": 2.46, "dayHigh": 2.56, "regularMarketPreviousClose": 2.49, "regularMarketOpen": 2.46, "regularMarketDayLow": 2.46, "regularMarketDayHigh": 2.56, "payoutRatio": 0.0, "beta": 2.034, "trailingPE": 11.714286, "forwardPE": -123.00001, "volume": 14450, "regularMarketVolume": 14450, "averageVolume": 123564, "averageVolume10days": 33470, "averageDailyVolume10Day": 33470, "bid": 2.46, "ask": 2.49, "marketCap": 79354680, "fiftyTwoWeekLow": 1.47, "fiftyTwoWeekHigh": 5.56, "priceToSalesTrailing12Months": 0.7244356, "fiftyDayAverage": 3.0628, "twoHundredDayAverage": 2.70525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "CAD", "tradeable": false, "enterpriseValue": 111794424, "profitMargins": 0.03252, "floatShares": 29865427, "sharesOutstanding": 32258000, "sharesShort": 12701, "sharesShortPriorMonth": 51004, "sharesShortPreviousMonthDate": 1739836800, "dateShortInterest": 1742169600, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.07029, "heldPercentInstitutions": 0.03125, "shortRatio": 0.16, "impliedSharesOutstanding": 32258000, "bookValue": 1.34, "priceToBook": 1.8358209, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": 3562000, "trailingEps": 0.21, "forwardEps": -0.02, "lastSplitFactor": "1:15", "lastSplitDate": 1545177600, "enterpriseToRevenue": 1.021, "enterpriseToEbitda": 5.334, "52WeekChange": 0.5092025, "SandP52WeekChange": 0.101756096, "quoteType": "EQUITY", "currentPrice": 2.46, "targetHighPrice": 10.0, "targetLowPrice": 3.45, "targetMeanPrice": 6.46429, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 7, "totalCash": 8441000, "totalCashPerShare": 0.262, "ebitda": 20960000, "totalDebt": 39913000, "quickRatio": 0.34, "currentRatio": 1.006, "totalRevenue": 109540000, "debtToEquity": 120.579, "revenuePerShare": 4.465, "returnOnAssets": 0.061350003, "returnOnEquity": 0.113690004, "grossProfits": 63412000, "freeCashflow": 13293750, "operatingCashflow": 23365000, "revenueGrowth": 0.19, "grossMargins": 0.57889, "ebitdaMargins": 0.19135, "operatingMargins": 0.12607001, "financialCurrency": "USD", "symbol": "MDP.TO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1743623999, "exchange": "TOR", "messageBoardId": "finmb_60832378", "exchangeTimezoneName": "America/Toronto", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "ca_market", "esgPopulated": false, "regularMarketChangePercent": -1.2048181, "regularMarketPrice": 2.46, "shortName": "MEDEXUS PHARMACEUTICALS INC", "longName": "Medexus Pharmaceuticals Inc.", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1389277800000, "regularMarketChange": -0.029999971, "regularMarketDayRange": "2.46 - 2.56", "fullExchangeName": "Toronto", "averageDailyVolume3Month": 123564, "fiftyTwoWeekLowChange": 0.99, "fiftyTwoWeekLowChangePercent": 0.67346936, "fiftyTwoWeekRange": "1.47 - 5.56", "fiftyTwoWeekHighChange": -3.1, "fiftyTwoWeekHighChangePercent": -0.55755395, "fiftyTwoWeekChangePercent": 50.92025, "dividendDate": 1545177600, "earningsTimestamp": 1738794624, "earningsTimestampStart": 1750968000, "earningsTimestampEnd": 1752177600, "earningsCallTimestampStart": 1738846800, "earningsCallTimestampEnd": 1738846800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.21, "epsForward": -0.02, "epsCurrentYear": 0.213, "priceEpsCurrentYear": 11.549296, "fiftyDayAverageChange": -0.6027999, "fiftyDayAverageChangePercent": -0.19681334, "twoHundredDayAverageChange": -0.24524999, "twoHundredDayAverageChangePercent": -0.09065705, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "cryptoTradeable": false, "marketState": "PREPRE", "trailingPegRatio": null}